Geode Capital Management LLC Sells 3,773 Shares of LifeVantage Co. (NASDAQ:LFVN)

Geode Capital Management LLC reduced its holdings in shares of LifeVantage Co. (NASDAQ:LFVN) by 3.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 119,066 shares of the company’s stock after selling 3,773 shares during the period. Geode Capital Management LLC owned about 0.95% of LifeVantage worth $1,439,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Ritholtz Wealth Management lifted its holdings in LifeVantage by 62.0% during the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after purchasing an additional 10,974 shares during the last quarter. Barclays PLC boosted its holdings in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock worth $507,000 after acquiring an additional 11,608 shares in the last quarter. HighTower Advisors LLC bought a new stake in LifeVantage during the 3rd quarter worth approximately $638,000. Capital Management Corp VA acquired a new stake in LifeVantage during the 3rd quarter valued at $5,073,000. Finally, Renaissance Technologies LLC raised its position in LifeVantage by 2.1% in the 2nd quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock valued at $5,490,000 after purchasing an additional 17,300 shares during the last quarter. Institutional investors own 35.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital initiated coverage on LifeVantage in a research note on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company.

LifeVantage Trading Up 21.4 %

Shares of NASDAQ LFVN opened at $19.97 on Friday. LifeVantage Co. has a 1-year low of $5.22 and a 1-year high of $24.00. The company has a 50-day moving average of $15.46 and a two-hundred day moving average of $11.34. The company has a market cap of $250.12 million, a PE ratio of 62.41 and a beta of 0.82.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The firm had revenue of $47.21 million for the quarter. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%.

LifeVantage Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date of this dividend was Monday, December 2nd. LifeVantage’s dividend payout ratio (DPR) is 50.00%.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.